Hutch News

Hutch News

Stories tagged 'south africa'

On World AIDS Day, renewed hope for an HIV vaccine

Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’

Dec. 1, 2016 | By Mary Engel / Fred Hutch News Service

World’s AIDS Day 2016 brings especially hopeful news: A large-scale clinical trial has opened in South Africa to test an experimental HIV vaccine regimen that could lead to the first licensed vaccine against the virus that causes AIDS.

View story >

Quest for an HIV vaccine

Community trust is key as researchers start a new trial across 15 sites in South Africa

Nov. 29, 2016 | By Mary Engel / Fred Hutch News Service

Dr. Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and a member of the Fred Hutch-based HIV Vaccine Trials Network, works closely with the communities most affected by HIV to end the epidemic. She is co-chairing a just-launched clinical trial in South Africa that could lead to the first licensed HIV vaccine.

View story >

Empowering ‘millions of women’ against HIV

AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands

Oct. 21, 2016 | By Mary Engel / Fred Hutch News Service

The AMP study in sub-Saharan Africa will test whether an antibody infusion protects women against HIV. If it does, the finding will have particular significance for an epidemic that hits women on that continent especially hard and for which they have few prevention options.

View story >

HIV vaccine clinical trial launches in South Africa

Community plays key role in testing a modified version of ‘Thai vaccine’ regimen

Feb. 18, 2015 | By Mary Engel / Fred Hutch News Service

As studies that could lead to the first licensed HIV vaccine get underway, a core partner in the effort is what is generally called “the community” – the thousands of volunteers who will take part in the trials and those who serve on volunteer community advisory boards.

View story >

HIV vaccine trial passes first hurdle in South Africa

‘Encouraging’ results lay groundwork for more trials in 2015

Oct. 28, 2014 | By Mary Engel

The first in a series of clinical trials designed to build on the promise of an HIV vaccine that showed modest protection when tested in Thailand has passed a key hurdle, according to a new study. It paves the way for larger HIV vaccine trials to move forward in South Africa.

View story >

'Rest in peace, Tata': South Africa mourns Nelson Mandela's death

Mandela, the country's first black president, was vocal about the clarity of science that unequivocally connected HIV with AIDS

Dec. 6, 2013 | By Glenda Gray, HIV Vaccine Trials Network co-principal investigator

Dr. Glenda Gray, co-prinicipal investigator of the HIV Vaccine Trials Network (HVTN) shares her perspective of Dr. Nelson Mandela following his death.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.